In summary, the genotype-specific changes in rotarod performance and cued fear memory, among others, show that KO mice do not display the same MPTP-related changes in behavior and cognitive performance as WT mice and, suggest that mGlu8 would be a worthwhile target to consider for developing PD therapeutics. This evidence concerns the gene GRM8 and Parkinson disease.